98404850

Information

• Trademark
• 98404850

• Source

• Serial Number

  98404850

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 14, 2024
  a year ago

• Transaction Date

  March 05, 2025
  5 days ago

• Status Date

  February 17, 2025
  21 days ago

• Published for Opposition Date

  March 11, 2025
  15 hours from now

• Location Date

  February 17, 2025
  21 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CHUO, EMILY

• Attorney Docket Number

  NEUB 2402663

  Attorney Name

  Allison Strickland Ricketts

• Owners

  • Neurocrine Biosciences, Inc.

Case File Statements

• DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow.
• GS0051: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
• CC0000: The color(s) purple, orange, and yellow is/are claimed as a feature of the mark.
• GS0441: providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
• GS0421: providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Case File Event Statements

• 2/14/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/5/2024 - 10 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/5/2024 - 10 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/15/2024 - 6 months ago

  10 - PRIORITY ACTION WRITTEN Type: CPRA

• 5/22/2024 - 9 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/30/2024 - 9 months ago

  7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 5/30/2024 - 9 months ago

  6 - PRIORITY ACTION E-MAILED Type: GPRA

• 5/30/2024 - 9 months ago

  5 - PRIORITY ACTION WRITTEN Type: CPRA

• 7/31/2024 - 7 months ago

  8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 7/31/2024 - 7 months ago

  9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 8/15/2024 - 6 months ago

  12 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 8/15/2024 - 6 months ago

  11 - PRIORITY ACTION E-MAILED Type: GPRA

• 8/27/2024 - 6 months ago

  13 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/27/2024 - 6 months ago

  14 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 2/7/2025 - a month ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/7/2025 - a month ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/7/2025 - a month ago

  15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/14/2025 - 24 days ago

  19 - ASSIGNED TO LIE Type: ALIE

• 3/5/2025 - 5 days ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/12/2025 - 26 days ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA